Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation

In this research, a variety of novel amphetamine derivatives were synthesized and assessed for their potential as multifaceted antidepressant agents. Among these compounds, compound <b>11b</b> demonstrated potent inhibitory effects on both serotonin and noradrenaline transporters (SERT/N...

Full description

Saved in:
Bibliographic Details
Main Authors: Quxiang Li, Lili Ren, Dongli Wang, Junyong Luo, Changda Xu, Jian Feng, Yufan Qiu, Xiangqing Xu, Guoguang Chen
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/22/5240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850227077936054272
author Quxiang Li
Lili Ren
Dongli Wang
Junyong Luo
Changda Xu
Jian Feng
Yufan Qiu
Xiangqing Xu
Guoguang Chen
author_facet Quxiang Li
Lili Ren
Dongli Wang
Junyong Luo
Changda Xu
Jian Feng
Yufan Qiu
Xiangqing Xu
Guoguang Chen
author_sort Quxiang Li
collection DOAJ
description In this research, a variety of novel amphetamine derivatives were synthesized and assessed for their potential as multifaceted antidepressant agents. Among these compounds, compound <b>11b</b> demonstrated potent inhibitory effects on both serotonin and noradrenaline transporters (SERT/NET) and high affinity for histamine H<sub>3</sub> receptor (H<sub>3</sub>R), and displayed low affinity for off-target receptors (H1, α1) and hERG channels, which can reduce the prolongation of the QT interval. Molecular docking studies offered a rational binding model of compound <b>11b</b> when it forms a complex with SERT, NET, and the histamine H<sub>3</sub> receptor. In vivo behavioral studies, compound <b>11b</b> dose-dependently reduced the immobility duration in the mouse FST and TST assays without a stimulatory effect on the locomotor activity. Furthermore, compound <b>11b</b> had a favorable pharmacokinetic profile in rats. Thus, compound <b>11b</b> has the potential to develop a novel class of drugs for the treatment of depression.
format Article
id doaj-art-e05243740b4b40e2a730afc8ab2aab32
institution OA Journals
issn 1420-3049
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-e05243740b4b40e2a730afc8ab2aab322025-08-20T02:04:55ZengMDPI AGMolecules1420-30492024-11-012922524010.3390/molecules29225240Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological EvaluationQuxiang Li0Lili Ren1Dongli Wang2Junyong Luo3Changda Xu4Jian Feng5Yufan Qiu6Xiangqing Xu7Guoguang Chen8School of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, ChinaSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, ChinaJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, ChinaSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, ChinaJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, ChinaJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, ChinaPharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, ChinaJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, ChinaSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, ChinaIn this research, a variety of novel amphetamine derivatives were synthesized and assessed for their potential as multifaceted antidepressant agents. Among these compounds, compound <b>11b</b> demonstrated potent inhibitory effects on both serotonin and noradrenaline transporters (SERT/NET) and high affinity for histamine H<sub>3</sub> receptor (H<sub>3</sub>R), and displayed low affinity for off-target receptors (H1, α1) and hERG channels, which can reduce the prolongation of the QT interval. Molecular docking studies offered a rational binding model of compound <b>11b</b> when it forms a complex with SERT, NET, and the histamine H<sub>3</sub> receptor. In vivo behavioral studies, compound <b>11b</b> dose-dependently reduced the immobility duration in the mouse FST and TST assays without a stimulatory effect on the locomotor activity. Furthermore, compound <b>11b</b> had a favorable pharmacokinetic profile in rats. Thus, compound <b>11b</b> has the potential to develop a novel class of drugs for the treatment of depression.https://www.mdpi.com/1420-3049/29/22/5240amphetaminemultitargetantidepressantmolecular docking
spellingShingle Quxiang Li
Lili Ren
Dongli Wang
Junyong Luo
Changda Xu
Jian Feng
Yufan Qiu
Xiangqing Xu
Guoguang Chen
Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
Molecules
amphetamine
multitarget
antidepressant
molecular docking
title Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
title_full Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
title_fullStr Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
title_full_unstemmed Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
title_short Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H<sub>3</sub> Agents: Synthesis and Biological Evaluation
title_sort amphetamine derivatives as potent central nervous system multitarget sert net h sub 3 sub agents synthesis and biological evaluation
topic amphetamine
multitarget
antidepressant
molecular docking
url https://www.mdpi.com/1420-3049/29/22/5240
work_keys_str_mv AT quxiangli amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT liliren amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT dongliwang amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT junyongluo amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT changdaxu amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT jianfeng amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT yufanqiu amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT xiangqingxu amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation
AT guoguangchen amphetaminederivativesaspotentcentralnervoussystemmultitargetsertnethsub3subagentssynthesisandbiologicalevaluation